Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Summary of Revenue by Major Source

The following table presents revenue by major source:

	For the Three Months Ended March 31,
	2022		2021
Direct to patient	$	1,852,144	$	1,701,930
Clinical/Medical providers		1,015,782		634,559
License revenue		1,000,000		-
Total revenue from contracts with customer	$	3,867,926	$	2,336,489

Summary of Potential Common Shares Issuable

Potential common shares issuable consist of the following at:

	March 31,
	2022		2021
Stock options		32,381		24,137
Restricted stock units		279,847		273,321
Restricted stock		-		30
Stock warrants		693,643		1,709,714
Total		1,005,871		2,007,202